{"pdb_id": "5aav", "method": ["X-RAY DIFFRACTION"], "title": "Optimization of a novel binding motif to to (E)-3-(3,5-difluoro-4-((1R,3R)-2-(2-fluoro-2-methylpropyl)-3-methyl-2,3,4,9-tetrahydro-1H- pyrido(3,4-b)indol-1-yl)phenyl)acrylic acid (AZD9496), a potent and orally bioavailable selective estrogen receptor downregulator and antagonist", "resolution": 1.95, "ncbi_taxon_id": 9606, "deposition_date": {"$date": "2015-07-29T00:00:00Z"}, "entity_id": "1", "entity_name": "ESTROGEN RECEPTOR", "entity_type": "polypeptide(L)", "num_molecules": 1, "pdb_chain": "A", "struct_asym": "A"}
{"pdb_id": "5aav", "method": ["X-RAY DIFFRACTION"], "title": "Optimization of a novel binding motif to to (E)-3-(3,5-difluoro-4-((1R,3R)-2-(2-fluoro-2-methylpropyl)-3-methyl-2,3,4,9-tetrahydro-1H- pyrido(3,4-b)indol-1-yl)phenyl)acrylic acid (AZD9496), a potent and orally bioavailable selective estrogen receptor downregulator and antagonist", "resolution": 1.95, "ncbi_taxon_id": 9606, "deposition_date": {"$date": "2015-07-29T00:00:00Z"}, "entity_id": "2", "entity_name": "ESTROGEN RECEPTOR", "entity_type": "polypeptide(L)", "num_molecules": 1, "pdb_chain": "B", "struct_asym": "B"}
